Mitochondria: important target for drug toxicity?

Review

S Krähenbühl. J Hepatol. 2001 Feb.

. 2001 Feb;34(2):334-6.

doi: 10.1016/s0168-8278(00)00106-9.

No abstract available

Comment on

Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation.
Berson A, Fau D, Fornacciari R, Degove-Goddard P, Sutton A, Descatoire V, Haouzi D, Lettéron P, Moreau A, Feldmann G, Pessayre D. Berson A, et al. J Hepatol. 2001 Feb;34(2):261-9. doi: 10.1016/s0168-8278(00)00050-7. J Hepatol. 2001. PMID: 11281555
Hepatitis after intravenous buprenorphine misuse in heroin addicts.
Berson A, Gervais A, Cazals D, Boyer N, Durand F, Bernuau J, Marcellin P, Degott C, Valla D, Pessayre D. Berson A, et al. J Hepatol. 2001 Feb;34(2):346-50. doi: 10.1016/s0168-8278(00)00049-0. J Hepatol. 2001. PMID: 11281569